Hexaware Positioned as a Leader in ISG’s Global 2025 Life Sciences Digital Services Report
July 1, 2025
Information Services Group (ISG), a leading global technology research and advisory firm, has recognized Hexaware as a Leader in two quadrants of the ISG Provider Lens™ Life Sciences Digital Services – Global 2025 report: Clinical Development and Patient Engagement. The report assesses service providers based on their capabilities to support digital transformation across the life sciences value chain. Some of the top service providers who have been called out as Leaders in the report in these quadrants are: Hexaware, HCLTech, and Infosys.
Hexaware was also identified as a Rising Star in the Commercial Operations – Digital Evolution quadrant, reflecting its momentum and future potential in that domain.
“Hexaware is clearly making a mark in life sciences. They’re leveraging AI to improve data quality and streamline clinical processes, while also enhancing patient interactions with smart, personalized platforms. Their work in commercial operations, especially with major CRM systems, shows a clear focus on boosting efficiency across the sector.” — Rohan Sinha, Manager & Principal Analyst
Clinical Development: Harnessing Advanced Automation and Data-Driven Insights
In the Clinical Development quadrant, ISG noted Hexaware’s suite of solutions that includes Clinical Data Automation as a Solution, Medical Writing as a Service, and Quality Compliance as a Service.
Key highlights from the report include:
- Advanced Clinical Data Automation: Hexaware’s Clinical Data Automation as a Solution (CDAaaS) leverages agentic AI to streamline data collection, standardization, and submission for preclinical and clinical studies, featuring components like a Metadata Repository, Clinical and Operational Data Repository, and eData Validator.
- Robust Medical Writing Services: Hexaware’s Medical Writing as a Service (MwaaS) combines human expertise with advanced software to produce over 14 types of regulatory documents, including Clinical Study Reports and Investigational Brochures using a one-click approach for first draft creation significantly streamlining the documentation process, enabling clients to efficiently meet regulatory requirements.
- Robust Quality Compliance and Decentralized Trials: Hexaware’s Quality Compliance as a Service (QcaaS) utilizes AI to enhance validation processes and ensure comprehensive quality checks, generating validation documents and synthetic data, confirming that all submissions meet the highest standards of compliance.
Patient Engagement: Blending AI with Personalized Care
In the Patient Engagement quadrant, ISG highlighted Hexaware’s focus on integrating GenAI with insights into patient journeys to promote personalized communication, boosting adherence to treatment protocols and improving collaboration among stakeholders for better health outcomes.
Key highlights from the report include:
- Holistic Patient-centric Approach: Hexaware’s omnichannel patient engagement platform empowers patients by providing a comprehensive view of their medical profiles and real-time access to health information for enhanced care coordination, personalized communication and active patient participation. By addressing the specific needs of patients, healthcare providers and pharmaceutical companies, Hexaware ensures a tailored experience that improves treatment adherence and elevates patient satisfaction.
- Emphasis on Speed and Efficiency: To enhance operational processes, Hexaware’s Medical Insights Bot delivers real-time insights, helping field teams and medical science liaisons make informed decisions. Moreover, its Content Hub streamlines content creation, reducing the time spent on approvals and dependency on external agencies.
- Innovative Integration of GenAI and Advanced Analytics: Hexaware leverages GenAI and advanced analytics to deliver personalized care experiences at scale. This enables providers to use these technologies to predict patient needs, create empathetic interactions, and optimize care plans. This integration enhances the overall patient experience while generating valuable insights.
Commercial Operations: Recognized as a Rising Star
Hexaware was recognized as a Rising Star in the Commercial Operations quadrant. ISG cited Hexaware’s:
- Robust Platform Support: Hexaware offers robust assistance using Salesforce and Veeva platforms, delivering numerous successful implementations, helping clients optimize these essential tools while offering migration resources that facilitate transitions to the Life Sciences Cloud, ensuring a smooth process for firms looking to modernize their systems.
- Emphasis on Speed and Efficiency: Recognizing the importance of timely market entry, Hexaware places a strong emphasis on speed and efficiency in its solutions. The company developed innovative tools that significantly enhance operational processes. For instance, the Medical Insights Bots deliver real-time insights, empowering field teams and medical science liaisons to make well-informed decisions swiftly. Also, Hexaware’s Content Hub optimizes the content creation process, drastically reducing approval times and lessening the reliance on external agencies.
- Improved Field Operations: Hexaware uses AI to optimize call planning, boosting sales representatives’ productivity and client engagement. Specialized support services also streamline onboarding and training, enabling the personnel to focus more effectively on their core tasks.
A Global Partner for Digital Transformation in Life Sciences
Hexaware’s inclusion in multiple quadrants reflects our end-to-end capabilities in transforming the life sciences industry with automation, analytics, cloud-native platforms, and integrated patient and HCP engagement solutions.
Hexaware Named a Leader in Clinical Development (service providers) in the ISG Provider Lens™ Life Sciences Digital Services 2025 Global Quadrant Study
“Hexaware transforms clinical development by harnessing advanced automation and data-driven insights, enabling organizations to enhance efficiency, ensure compliance and prioritize patient engagement for improved healthcare outcomes.”
— Rohan Sinha, Lead Author, Life Sciences Digital Services Study
Hexaware Named a Leader in Patient Engagement (service providers) in the ISG Provider Lens™ Life Sciences Digital Services 2025 Global Quadrant Study
“Hexaware stands out in patient engagement, seamlessly blending AI with personalized care to drive positive health outcomes and elevate patient experiences.”
— Sneha Jayanth, Co-Author and Research Analyst, Life Sciences Digital Services Study
Hexaware Named a Rising Star in Commercial Operations – Digital Evolution (service providers) in the ISG Provider Lens™ Life Sciences Digital Services 2025 Global Quadrant Study
“Hexaware is leading the charge in life sciences with innovative AI, strategic partnerships and IPO success.”
— Sneha Jayanth, Co-Author and Research Analyst, Life Sciences Digital Services Study
To learn more, visit our Life Sciences and Healthcare Services page.